The Impact of Obesity and Obesity Treatments on Breast Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of Avandamet
that can be given in combination with exemestane to patients who are obese and postmenopausal
with hormone-receptive-positive breast cancer that has spread to other parts of the body.